| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Mensinger Mike73 | Chief Product Officer | Sell | 1,115 | $17.89 | $19,947.78 | -0.4% | +1.8% | -31.6% | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Feider Stephen71 | Chief Financial Officer | Sell | 1,497 | $17.89 | $26,783.06 | -1.1% | +1.8% | -31.6% | |
| Jun 2, 2025 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 41 | $243.78 | $9,994.98 | -0.5% | +11.0% | -23.6% | |
| Jun 2, 2025 | LUNG Pulmonx Corp | Joshi Mehul73 | Chief Financial Officer &Pao | Sell | 8,061 | $3.13 | $25,230.93 | -1.8% | -44.7% | -48.6% | |
| Jun 2, 2025 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $258.17 | $154,903.21 | - | +5.2% | +24.5% | |
| Jun 2, 2025 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 6,947 | $3.13 | $21,748.12 | -0.4% | -44.7% | -48.6% | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Saint Sean60 | President &CEO | Sell | 3,439 | $17.89 | $61,525.65 | -1.1% | +1.8% | -31.6% | |
| Jun 2, 2025 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 164,443 | $103.69 | $17,051,135.67 | -5.1% | +2.4% | -54.2% | |
| Jun 2, 2025 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 2,570 | $77.40 | $198,911.32 | -4.9% | +4.7% | +12.2% | |
| Jun 2, 2025 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $243.78 | $243,780.00 | -1.2% | +11.0% | -23.6% | |
| Jun 2, 2025 | NVCR Novocure Ltd | Leonard Frank X76 | EVP, Pres., Novocure Oncology | Sell | 30,196 | $17.50 | $528,412.59 | -5.5% | -28.5% | -7.2% | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Hopman Mark57 | Chief Commercial Officer | Sell | 868 | $17.89 | $15,529.30 | -0.8% | +1.8% | -31.6% | |
| Jun 2, 2025 | BDX Becton Dickinson & Co | Shan David48 | EVP And Chief Isc Officer | Sell | 1,166 | $171.19 | $199,607.54 | -20.3% | +11.7% | +10.3% | |
| Jun 2, 2025 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 10,457 | $3.13 | $32,735.76 | -0.7% | -44.7% | -48.6% | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | Sell | 1,039 | $17.89 | $18,588.21 | -0.5% | +1.8% | -31.6% | |
| Jun 2, 2025 | LUNG Pulmonx Corp | Williamson Steven S.83 | President And CEO | Sell | 9,923 | $3.13 | $31,058.99 | -1.3% | -44.7% | -48.6% | |
| Jun 2, 2025 | IRTC Irhythm Holdings, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | Sell | 696 | $140.21 | $97,586.16 | -5.9% | +21.6% | -22.4% | |
| Jun 2, 2025 | MLSS Milestone Scientific Inc. | Bp4 S.r.l.89 | 10% Owner | Sell | 22,118 | $0.94 | $20,744.22 | -0.1% | -37.3% | -59.6% | |
| Jun 2, 2025 | MMSI Merit Medical Systems Inc | McDonnell Michael R. | Director | Sell | 3,500 | $94.41 | $330,417.50 | -19.4% | -3.2% | -35.2% | |
| Jun 2, 2025 | INCY Incyte Corp | Tray Thomas55 | Principal Accounting Officer | Sell | 1,614 | $65.38 | $105,515.61 | -3.5% | +31.6% | - | |
| Jun 2, 2025 | IRTC Irhythm Holdings, Inc. | Shrishrimal Sumi60 | EVP, Chief Risk Officer | Sell | 1,608 | $140.21 | $225,457.68 | -4.4% | +21.6% | -22.4% | |
| May 30, 2025 | MMSI Merit Medical Systems Inc | Floyd David | Director | Sell | 3,515 | $94.16 | $330,972.40 | -41.9% | -5.2% | -33.6% | |
| May 30, 2025 | ICUI Icu Medical Inc/de | Sanzone Virginia Ruth64 | VP, General Counsel | Sell | 700 | $133.62 | $93,537.08 | -9.9% | -5.8% | +0.4% | |
| May 30, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 1,000 | $2.22 | $2,220.00 | -0.3% | +12.9% | - | |
| May 30, 2025 | MMSI Merit Medical Systems Inc | Lampropoulos Fred P.66 | President And CEO | Sell | 10,000 | $95.12 | $951,200.00 | -0.9% | -5.2% | -33.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.